Profile to raise $40 million for smart inhaler:
This article was originally published in Clinica
Executive Summary
Profile Therapeutics plans to raise £25.5 million ($40 million) on the London Stock Exchange. The Bognor Regis, Sussex-based company is developing inhaled drug delivery systems, based around its Adaptive Aerosol Delivery technology, which produces reproducible and precise doses by adapting to patients' breathing patterns. The company, which began as an inhaler distributor in 1977, launched its first product, the HaloLite system, in 1998. Its present turnover is around £10 million and the flotation, due for March 31, values the company at £81 million.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.